Aurobindo completes $210M Lannett acquisition in US

Aurobindo completes $210M Lannett acquisition in US — Aurobindo Pharma USA Inc., a wholly owned subsidiary, has completed the acquisition of Lannett Company Inc. for $210 million. This strategic move strengthens Aurobindo’s presence in the US generics market. The integration is expected to enhance product portfolio and revenue streams.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition